Journal of Clinical Research and Pharmacy

Journal of Clinical Research and Pharmacy 44 7897 074717

Free Online Peer Reviewed Pharmacoproteomics Journals

Pharmacoproteomics is the procedure of proteomic technologies in drug finding and progress. Along with pharmacogenomics and pharmacogenetics, pharmacoproteomics will play a significant role in the expansion of modified medicines in numerous ways. Proteomic technologies are causative to molecular diagnostics, which is a basis of modified treatment. Pharmacoproteomics is a more efficient illustration of patient-to-patient dissimilarity than that provided by genotyping. Proteomics-based classification of multifactorial infections may help to match a particular target-based rehabilitation to a particular marker in a subgroup of patients. Individualized therapy may be based on variance protein expression rather than a genetic polymorphism. Finally, proteomic technologies would enable detection and development of drugs suitable for modified therapy. Protein chips will be used progressively in medical diagnostics in the succeeding 5 ages, particularly in the point-of-care diagnostics. This will enable the practice of modified medicine in the clinic by the end of this era.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences

Get the App